Cero Terapeutics Hldg Inc (CERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,148 | 4,552 | 1,287 | 1,536 | 2,414 |
| Operating Income | -5,148 | -4,552 | -1,287 | -1,536 | -2,414 |
| Interest Expense | 17 | 10 | 0 | 0 | -59 |
| Other Income | 2,717 | 2,262 | -122 | 186 | 262 |
| Pre-tax Income | -2,449 | -2,300 | -1,409 | -1,349 | -2,093 |
| Net Income Continuous | -2,449 | -2,300 | -1,409 | -1,349 | -2,093 |
| Net Income | $-2,449 | $-2,300 | $-1,409 | $-1,349 | $-2,093 |
| EPS Basic Total Ops | -302.32 | -326.20 | -23,672.80 | -300.00 | -460.00 |
| EPS Basic Continuous Ops | -302.34 | -326.20 | -23,675.25 | -297.58 | -461.75 |
| EPS Diluted Total Ops | -302.32 | -326.20 | -23,672.80 | -300.00 | -460.00 |
| EPS Diluted Continuous Ops | -302.34 | -326.20 | -23,675.25 | -297.58 | -461.75 |
| EPS Diluted Before Non-Recurring Items | -660.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-4,855 | $-4,266 | $-1,003 | $-1,254 | $-2,136 |